Skip to main content


Cardiology and Therapy


Cardiology and Therapy OnlineFirst articles

Open Access 24.09.2022 | Original Research

Impact of Cardiovascular Risk Factors on Arterial Stiffness in a Countryside Area of Switzerland: Insights from the Swiss Longitudinal Cohort Study

Cardiovascular disease is the leading cause of morbidity and mortality worldwide [ 1 ]. It is recognized that the individual risk of cardiovascular disease is dependent, in addition to age, on various factors, such as arterial hypertension …

Open Access 21.09.2022 | Original Research

Comparison of Two Different Rota-Flush Solutions in Patients Undergoing Rotational Atherectomy: A Randomized, Controlled, Triple-Blind Trial

Rotational atherectomy (RA) was first utilized to treat obstructive coronary diseases by Jarome Ritchie and colleagues in 1987 [ 1 ], and thereafter has been widely applied to modify plaque compliance and allow smooth passage for stents in highly …

Open Access 08.09.2022 | Original Research

Utility of Follow-Up Echocardiograms in Uncomplicated PDA Device Closures Performed During Infancy

A patent ductus arteriosus (PDA) represents the most common cardiovascular condition of preterm infants and its incidence is inversely related to gestational age at birth. Recent evidence suggests that 50–70% of infants born at less than 28 weeks …

Open Access 02.09.2022 | Commentary

The Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) Perspectives on the Usage of Inclisiran

The role of low-density lipoprotein cholesterol (LDL-c) as an atherogenic particle in the process of atherosclerosis is essential. With that in mind, the reduction of LDL-c in the blood has been proven to lower cardiovascular events and mortality.

Open Access 13.08.2022 | Review

Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review

The prevalence of hypertension and comorbidities such as metabolic syndrome, diabetes mellitus, and chronic kidney disease in India is alarmingly high. Amlodipine, an older-generation calcium channel blocker (CCB), is currently the gold standard …

Über diese Zeitschrift

Cardiology and Therapy is an international, open access, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of cardiovascular therapies and interventions, including devices. Studies relating to diagnosis and diagnostics, pharmacoeconomics, public health, quality of life, as well as patient care, management and education are also encouraged.

Areas of focus include, but are not limited to, ischaemic heart disease and acute cardiac care, myocardial, valvular, pericardial and congenital heart disease, vascular and pulmonary disease (including hypertension), arrhythmias, heart failure, non-invasive diagnostic techniques, and invasive and interventional cardiology as well as cardiovascular surgery.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.

Moving forward from traditional publishing, Cardiology and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include slide sets, videos, animations, and/or interactive learning resources. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

Cardiology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here:

Upon acceptance of your article for publication, you will be required to pay the article processing charge of £210/$330 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

For more information about the journal, please contact or see the News page for the latest journal offers.

Cardiology and Therapy
Volume 1/2012 - Volume 11/2022
Springer Healthcare
Elektronische ISSN
Print ISSN

Neu im Fachgebiet Innere Medizin


Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.